534 related articles for article (PubMed ID: 24907930)
1. Discerning the kinetics of autoimmune manifestations in a model of Sjögren's syndrome.
Karnell JL; Mahmoud TI; Herbst R; Ettinger R
Mol Immunol; 2014 Dec; 62(2):277-82. PubMed ID: 24907930
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome.
Prochorec-Sobieszek M; Wagner T; Loukas M; Chwalińska-Sadowska H; Olesińska M
Med Sci Monit; 2004 Apr; 10(4):BR115-21. PubMed ID: 15039641
[TBL] [Abstract][Full Text] [Related]
3. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
4. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
Front Immunol; 2018; 9():2661. PubMed ID: 30519241
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
6. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune response and target autoantigens in Sjogren's syndrome.
Routsias JG; Tzioufas AG
Eur J Clin Invest; 2010 Nov; 40(11):1026-36. PubMed ID: 20629708
[TBL] [Abstract][Full Text] [Related]
8. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
Voynova E; Lefebvre F; Qadri A; Muller S
J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
[TBL] [Abstract][Full Text] [Related]
9. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
10. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune manifestations in aged mice arise from early-life immune dysregulation.
Mahmoud TI; Wang J; Karnell JL; Wang Q; Wang S; Naiman B; Gross P; Brohawn PZ; Morehouse C; Aoyama J; Wasserfall C; Carter L; Atkinson MA; Serreze DV; Braley-Mullen H; Mustelin T; Kolbeck R; Herbst R; Ettinger R
Sci Transl Med; 2016 Oct; 8(361):361ra137. PubMed ID: 27798262
[TBL] [Abstract][Full Text] [Related]
12. NOD.H-2h4 mice: an important and underutilized animal model of autoimmune thyroiditis and Sjogren's syndrome.
Braley-Mullen H; Yu S
Adv Immunol; 2015; 126():1-43. PubMed ID: 25727287
[TBL] [Abstract][Full Text] [Related]
13. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
14. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome.
Stott DI; Hiepe F; Hummel M; Steinhauser G; Berek C
J Clin Invest; 1998 Sep; 102(5):938-46. PubMed ID: 9727062
[TBL] [Abstract][Full Text] [Related]
15. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice.
Kurien BT; Dsouza A; Igoe A; Lee YJ; Maier-Moore JS; Gordon T; Jackson M; Scofield RH
Clin Exp Immunol; 2013 Jul; 173(1):67-75. PubMed ID: 23607771
[TBL] [Abstract][Full Text] [Related]
16. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
Peck AB; Nguyen CQ; Ambrus J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
[TBL] [Abstract][Full Text] [Related]
17. B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF.
Varin MM; Le Pottier L; Youinou P; Saulep D; Mackay F; Pers JO
Autoimmun Rev; 2010 Jul; 9(9):604-8. PubMed ID: 20457281
[TBL] [Abstract][Full Text] [Related]
18. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
[TBL] [Abstract][Full Text] [Related]
19. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
20. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
